The use of enoxaparin [Lovenox; sanofi-aventis] compared to unfractionated heparin for short term antithrombotic therapy in atrial fibrillation patients undergoing TEE guided cardioversion: Assessment of cardioversion using transesophageal echocardiography (ACUTE) II randomized multicenter study.

Trial Profile

The use of enoxaparin [Lovenox; sanofi-aventis] compared to unfractionated heparin for short term antithrombotic therapy in atrial fibrillation patients undergoing TEE guided cardioversion: Assessment of cardioversion using transesophageal echocardiography (ACUTE) II randomized multicenter study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Enoxaparin sodium (Primary) ; Heparin
  • Indications Atrial fibrillation; Stroke; Thromboembolism; Thrombosis
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms ACUTE-II
  • Most Recent Events

    • 12 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top